These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1948870)

  • 21. Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study.
    Watkins C; Moore L; Harvey I; Carthy P; Robinson E; Brawn R
    BMJ; 2003 May; 326(7400):1178-9. PubMed ID: 12775618
    [No Abstract]   [Full Text] [Related]  

  • 22. Dramaturgical study of meetings between general practitioners and representatives of pharmaceutical companies; Commentary: dramaturgical model gives valuable insight.
    Somerset M; Weiss M; Fahey T
    BMJ; 2001 Dec 22-29; 323(7327):1481-4. PubMed ID: 11751364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How good is communication between primary care physicians and subspecialty consultants?
    McPhee SJ; Lo B; Saika GY; Meltzer R
    Arch Intern Med; 1984 Jun; 144(6):1265-8. PubMed ID: 6732382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A national survey on the effect of pharmaceutical promotion on medical students.
    Vainiomäki M; Helve O; Vuorenkoski L
    Med Teach; 2004 Nov; 26(7):630-4. PubMed ID: 15763854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of legislative changes in drug promotion on medical students: questionnaire survey.
    Vuorenkoski L; Valta M; Helve O
    Med Educ; 2008 Dec; 42(12):1172-7. PubMed ID: 19120947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners?
    Roughead EE; Gilbert AL; Harvey KJ
    Int J Health Serv; 1998; 28(2):269-79. PubMed ID: 9595344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study.
    Anadaleeb SS; Tallman RF
    Health Mark Q; 1996; 13(4):79-89. PubMed ID: 10159647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visits by pharmaceutical representatives in general practice as observed by fifth-year medical students.
    Straand J; Cooper J
    Tidsskr Nor Laegeforen; 2018 Jan; 138(1):. PubMed ID: 29313642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Family doctors' views of pharmaceutical sales representatives: assessment scale development.
    Kersnik J; Klemenc-Ketis Z; Petek-Ster M; Tusek-Bunc K; Poplas-Susic T; Kolsek M
    Fam Pract; 2011 Aug; 28(4):456-60. PubMed ID: 21292626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Communication between general practitioners and hospital interns at emergency admissions].
    Frihagen F; Hjortdahl P; Kvamme OJ
    Tidsskr Nor Laegeforen; 1999 Jun; 119(15):2168-72. PubMed ID: 10402909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promotional methods used by representatives of drug companies: a prospective survey in general practice.
    Schramm J; Andersen M; Vach K; Kragstrup J; Kampmann JP; Søndergaard J
    Scand J Prim Health Care; 2007 Jun; 25(2):93-7. PubMed ID: 17497486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. General practitioners and pharmacists interprofessional communication.
    Ruth D; Constable V; Daffey J; Dammery D; Hodge MM; Hogan C; Liddell M; Lloyd A
    Aust Fam Physician; 1994 Aug; 23(8):1544-6. PubMed ID: 7980154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. General practitioners' views on the role of the community pharmacist.
    Ellis BC; Dovey SM; Collins DM; Tilyard MW; Clark DW
    N Z Med J; 1992 Oct; 105(943):403-5. PubMed ID: 1461595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The self-perceived role and educational needs of pharmaceutical representatives: a survey.
    O'Donnell MJ; Molloy DW; Smith SD; Dubois S; Russo RM
    Educ Health (Abingdon); 2004 Nov; 17(3):339-45. PubMed ID: 15848821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physicians' perceptions and uses of commercial drug information sources: an examination of pharmaceutical marketing to physicians.
    Spiller LD; Wymer WW
    Health Mark Q; 2001; 19(1):91-106. PubMed ID: 11727295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
    Castresana L; Mejia R; Aznar M
    Medicina (B Aires); 2005; 65(3):247-51. PubMed ID: 16042137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Community health services--more stressing for female than male physicians?].
    Buxrud EG
    Tidsskr Nor Laegeforen; 1990 Oct; 110(25):3260-4. PubMed ID: 2256044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stress, anxiety, and depression in hospital consultants, general practitioners, and senior health service managers.
    Caplan RP
    BMJ; 1994 Nov; 309(6964):1261-3. PubMed ID: 7888846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Communications between general practitioners and consultants.
    Long A; Atkins JB
    Br Med J; 1974 Nov; 4(5942):456-9. PubMed ID: 4425921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.